| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 681640 | GDSC1000 | pan-cancer | AAC | -0.071 | 0.05 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.06 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | -0.064 | 0.06 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.06 |
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.06 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | 0.067 | 0.06 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | 0.069 | 0.06 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.06 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.06 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.067 | 0.06 |